Xiidra Approved on January 20, 2017

Posted in Latest News on January 20, 2017.

Effective January 20, 2017, Rule 64B13-18.002, F.A.C. adds Xiidra (Lifitegrast Ophthalmic Solution) 5% to the formulary and allows Florida Optometrists to prescribe the medication to their patients.



More Latest News

Important Information Regarding Rhopressa
June 26, 2018

Click here to find out more about Rule 64B13-18.002 formulary of Topical Ocular Pharmaceutical Agents, Rhopressa (netarsudil ophthalmic solution) 0.02%.) Continue reading


Third Quarterly Performance Report Released for the 2017-2018 Fiscal Year
June 8, 2018

The Quarterly Performance Report for the third quarter of the 2017-2018 fiscal year is now available online. Continue reading